IOB - Delayed Quote EUR

Poxel S.A. (0RA2.IL)

Compare

0.2995

-0.0035

(-1.16%)

At close: 5:18:13 PM GMT

No Tool

Measure

UNDO

Redo

All

Favorites

Text

Statistics

Technicals

Fibonacci

Markings

Lines

Annotation

Arrow

Line

Horizontal

Vertical

Rectangle

Trend Line

Measurement Line

Average Line

Callout

Channel

Check

Continuous

Crossline

Elliott Wave

Ellipse

Doodle

Fib Projection

Fib Arc

Fib Fan

Fib Time Zone

Focus

Gann Fan

Gartley

Heart

Pitchfork

Quadrant Lines

Ray

Regression Line

Fib Retracement

Star

Speed Resistance Arc

Speed Resistance Line

Time Cycle

Tirone Levels

Volume Profile

Cross

Loading Chart for 0RA2.IL

Poxel Announces its Financial Calendar for 2025

Poxel: Ordinary and Extraordinary General Meeting to Be Held on February 11, 2025

Poxel Announces the Grant of Patent in China Protecting the Use of Imeglimin for Type-2 Diabetic Patients with Renal Impairment

Poxel to receive sales-based payment and higher level of royalties from Sumitomo Pharma in Q1 2025 for TWYMEEG® Achieving JPY 5 billion Net Sales in Japan

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Poxel S.A. (0RA2.IL)

Comparisons

Indicators

Technicals

Corporate Events

-10.93%

110.32%

-10.80%

-50.94%

121.20%

-20.71%

-97.33%

-96.33%

Recent News: 0RA2.IL

Poxel Announces its Financial Calendar for 2025

Poxel: Ordinary and Extraordinary General Meeting to Be Held on February 11, 2025

Poxel Announces the Grant of Patent in China Protecting the Use of Imeglimin for Type-2 Diabetic Patients with Renal Impairment

Poxel to receive sales-based payment and higher level of royalties from Sumitomo Pharma in Q1 2025 for TWYMEEG® Achieving JPY 5 billion Net Sales in Japan

Availability of Poxel’s 2024 Half-Year Financial Report

Poxel Reports Financial Results for First Half 2024 and Provides an Update on its Financial Position and Outlook

Poxel Announces Results from November 28, 2024 Annual General Meeting

Poxel Announces that its Annual General Meeting Will Be Held on November 28, 2024, at 9 am CET and the Availability of Preparatory Documents

Poxel Reports Cash and Revenue for the Third Quarter and Nine Months 2024 and Provides Corporate Update

Poxel Announces Availability of the 2023 Universal Registration Document

Poxel SA (STU:7PO) Full Year 2023 Earnings Call Highlights: Strategic Moves and Financial Challenges